交易成本视角下我国生物医药孵化器建设存在问题及对策  

Problems and Countermeasures of Biomedical Incubator Construction in China Under Transaction Cost Perspective

作　　者：赖秋洁 茅宁莹[1] Lai Qiujie;Mao Ningying(International Pharmaceutical Business School,China Pharmaceutical University,Nanjing 211198,China)

机构地区：[1]中国药科大学国际医药商学院,江苏南京211198

出　　处：《科技管理研究》2021年第20期97-105,共9页Science and Technology Management Research

基　　金：国家社会科学基金重大项目“我国创新药物政策环境研究”(15ZDB167);江苏省科技计划政策引导类(软科学研究)项目“产学研深度融合的江苏省生物医药技术创新体系建设研究”(BR2020089)。

摘　　要：从交易成本理论视角来看,生物医药孵化器具有实现创新资源共享、降低市场交易成本等作用,在运营发展过程中也会产生比较高的信息成本、协调成本及监督成本。分入孵、在孵两个阶段,分析提出我国生物医药孵化器运营成本问题的成因,主要包括信息共享不足、运行机制不够健全以及监督体系有待完善等,结合对美国强生JLabs生物医药孵化器的案例分析,从交易成本视角为降低我国生物医药孵化器运营成本、提高孵化能力,提出加强信息共享建设、制定健全运行机制和构建完善监督体系等具体对策建议。From the perspective of transaction cost theory, biomedical incubators not only help to achieve innovative resource sharing and reduce market transaction costs, but also produce relatively high information costs, coordination costs and supervision costs in the process of operation and development. Divided into two stages of entering the incubation and hatching, this paper analyzes and puts forward that the causes of operation cost of biomedical incubator in China mainly includes insufficient information sharing, imperfect operation mechanism and imperfect supervision system. Combined with the case analysis of Johnson & Johnson JLabs biomedical incubator in the United States, aiming at reducing the operation cost of biomedical incubators in China and improving the incubation ability, the paper puts forward specific countermeasures and suggestions such as strengthening the construction of information sharing, formulating and perfecting the operation mechanism and constructing and perfecting the supervision system.

关 键 词：生物医药孵化器 技术创新服务 资源共享 信息成本 

分 类 号：F272.3[经济管理—企业管理] G311[经济管理—国民经济]